23andMe has gotten the go-ahead from the US Food and Drug Administration to sell its genetic health risk report on three BRCA1 and BRCA2 mutations that increase a person's chances of developing breast cancer, as GenomeWeb reports. These variants are most common among people of Ashkenazi Jewish descent, though they are found to a lesser degree among individuals of other ethnic backgrounds.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.